Steroid Minimization in Adults with Minimal Change Disease.

Abbal Koirala, J Ashley Jefferson
{"title":"Steroid Minimization in Adults with Minimal Change Disease.","authors":"Abbal Koirala,&nbsp;J Ashley Jefferson","doi":"10.1159/000517626","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Minimal change disease (MCD) causes approximately 10% of nephrotic syndrome in adults. While glucocorticoids (GCs) effectively induce remission in MCD, the disease has a high relapse rate (50-75%), and repeated exposure to GCs is often required. The adverse effects of GCs are well recognized and commonly encountered with the high doses and recurrent courses used in MCD.</p><p><strong>Summary: </strong>In this review, we will discuss the standard therapy of MCD in adults and then describe new therapeutic options in induction therapy and treatment of relapses in MCD, minimizing the exposure to GCs.</p><p><strong>Key messages: </strong>Steroid minimization strategies may decrease adverse effects in the treatment of MCD.</p>","PeriodicalId":73177,"journal":{"name":"Glomerular diseases","volume":"1 4","pages":"237-249"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/39/14/gdz-0001-0237.PMC9677715.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Glomerular diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000517626","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Minimal change disease (MCD) causes approximately 10% of nephrotic syndrome in adults. While glucocorticoids (GCs) effectively induce remission in MCD, the disease has a high relapse rate (50-75%), and repeated exposure to GCs is often required. The adverse effects of GCs are well recognized and commonly encountered with the high doses and recurrent courses used in MCD.

Summary: In this review, we will discuss the standard therapy of MCD in adults and then describe new therapeutic options in induction therapy and treatment of relapses in MCD, minimizing the exposure to GCs.

Key messages: Steroid minimization strategies may decrease adverse effects in the treatment of MCD.

患有最小变化疾病的成人类固醇减量治疗。
背景:微小改变病(MCD)导致大约10%的成人肾病综合征。虽然糖皮质激素(GCs)可以有效地诱导MCD缓解,但该疾病的复发率很高(50-75%),并且经常需要反复使用GCs。GCs的不良反应是公认的,并且在MCD中使用的高剂量和复发疗程中经常遇到。摘要:在这篇综述中,我们将讨论成人MCD的标准治疗,然后描述诱导治疗和MCD复发治疗的新治疗选择,最大限度地减少对GCs的暴露。关键信息:类固醇最小化策略可以减少MCD治疗中的不良反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信